<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02651935</url>
  </required_header>
  <id_info>
    <org_study_id>IGHCEAH-ICU-3</org_study_id>
    <nct_id>NCT02651935</nct_id>
  </id_info>
  <brief_title>Intellivent ASV in Chronic Obstructive Pulmonary Disease Patients in the ICU</brief_title>
  <official_title>A Randomized Controlled Trial Comparing a Fully Closed Loop Ventilation Mode (Intellivent ASV) With Pressure Controlled + Pressure Support Ventilation in COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effect of a fully closed loop ventilation mode (Intellivent ASV)&#xD;
      on the duration of ventilation compared to conventional modes in COPD patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COPD patients often need invasive mechanical ventilation and due to the difficulties in the&#xD;
      weaning of these patients, duration of mechanical ventilation can be relatively longer when&#xD;
      compared with other ICU patients. Automated systems show promising results in shortening the&#xD;
      weaning time in some patient groups. The aim of this study is to evaluate the effect of&#xD;
      Intellivent-ASV with Quickwean function on the total duration of invasive mechanical&#xD;
      ventilation as a primary outcome. Secondary outcomes are success rate and duration of&#xD;
      weaning, ventilator free days at day 28 and intubation free days at day 28 (including NIV)&#xD;
      when compared to conventional ventilation with t-piece weaning.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">February 2019</completion_date>
  <primary_completion_date type="Actual">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of intubation</measure>
    <time_frame>24th month</time_frame>
    <description>Time from intubation until extubation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of mechanical ventilation (NIV included)</measure>
    <time_frame>24th month</time_frame>
    <description>Total time patient remains on mechanical ventilation support (invasive or noninvasive)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of manual settings</measure>
    <time_frame>24th month</time_frame>
    <description>Number of adjusments made manually to set the ventilator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of blood gas analysis tests</measure>
    <time_frame>24th month</time_frame>
    <description>Number of arterial blood gas tests under mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weaning duration</measure>
    <time_frame>24th month</time_frame>
    <description>Time from the beginning of weaning until extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent on spontaneous ventilation</measure>
    <time_frame>24th month</time_frame>
    <description>Time patient actively triggers the ventilator</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Intellivent ASV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will be ventilated with Intellivent ASV. Intellivent ASV is an automatic close loop ventilation mode. FiO2 setting will be automatically adjusted according to patients SpO2 and minute volume will be automatically adjusted according to patients EtCO2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCV+PSV</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>PCV+PSV is a conventional ventilation strategy of pressure controlled ventilation PCV) and pressure support ventilation (PSV).In this arm, FiO2, pressure control levels, respiratory frequency and all the ventilator settings will be manually adjusted by the physicians in charge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intellivent ASV</intervention_name>
    <description>Automated Invasive mechanical ventilation and weaning strategy</description>
    <arm_group_label>Intellivent ASV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COPD patients intubated and mechanically ventilated for less than 24 hours (Including&#xD;
             patients who received NIV before intubation)&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Written and/or informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Septic shock&#xD;
&#xD;
          -  Tracheostomy and/or home mechanical ventilation&#xD;
&#xD;
          -  Expected poor short term prognosis&#xD;
&#xD;
          -  Cardiac arrest with a poor neurological prognosis&#xD;
&#xD;
          -  ARDS&#xD;
&#xD;
          -  Broncho-pleural fistula&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilknur Naz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Izmir Chest Diseases and Surgery Training Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Burcu CINLETI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Izmir Chest Diseases and Surgery Training Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Huseyin OZKARAKAS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Izmir Chest Diseases and Surgery Training Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tunzala YAVUZ</last_name>
    <role>Principal Investigator</role>
    <affiliation>Izmir Chest Diseases and Surgery Training Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit</name>
      <address>
        <city>Izmir</city>
        <zip>35210</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 6, 2015</study_first_submitted>
  <study_first_submitted_qc>January 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2016</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Cenk Kirakli, M.D.</investigator_full_name>
    <investigator_title>Associate Professor, Pulmonary and Critical Care Medicine</investigator_title>
  </responsible_party>
  <keyword>Respiration, Artificial</keyword>
  <keyword>weaning</keyword>
  <keyword>critical care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

